Inaugural Global Rare Impact Award: Sanofi Honors The 3 Remarkable Pioneers
Ekaterina Kazakova, Medical Executive at Sanofi, reposted from Alaa Hamed on LinkedIn:
”Proud to share this meaningful initiative led by Sanofi recognizing leaders who have dedicated their lives to improving the rare disease landscape.
Projects like this are essential for raising awareness, strengthening patient advocacy, and highlighting the extraordinary efforts driving progress for rare communities worldwide.
We need more initiatives like this across all continents to ensure broader visibility, support, and impact.”
Quoting Alaa Hamed‘s post:
”Last week, at our Inaugural Global Rare Impact Awards ceremony November 14, 2025 in Vienna, we honored three remarkable pioneers:
Tiffany House A visionary leader in global patient advocacy, particularly in the Pompe community, setting the gold standard for collaborative advocacy leadership worldwide.
Maryze Schoneveld van der Linde A beacon of hope for rare disease patients in developing countries, distinguished board member of the International Pompe Association, and tireless advocate for patient needs globally.
Dr. I. C. Verma Known as the “Father of Genetics” in India, Dr. Verma established two groundbreaking genetic centers and pioneered affordable genetic testing.
His compassionate access program has helped treat over 300 patients with lysosomal storage disorders.
We are pleased to recognize these exceptional individuals who have dedicated their lives to transforming the rare disease landscape and those who have demonstrated outstanding leadership and unwavering commitment to the rare disease community for more than two decades.
This award embodies Sanofi’s commitment to recognizing those remarkable individuals who have dedicated their lives to advancing rare disease causes.
Their tireless efforts have created lasting changes in the rare disease community, improving countless lives worldwide.”
More winner stories featured in Hemostasis Today.
-
Jun 25, 2026, 05:26Paola Mendez Hiraldo: Glenn Ruperto’s Stroke Recovery and the Power of Team-Based Care
-
Jun 25, 2026, 05:19Steven Bell: Lessons in Rapid Stroke Care from Vall d’Hebron University Hospital
-
Jun 25, 2026, 04:48Brianne Martin: Stroke Recovery Is More Than Medical Appointments
-
Jun 24, 2026, 22:30The Clinical Impact of Anaphylaxis-Associated Coagulopathy – JTH
-
Jun 24, 2026, 21:08Martin Haluzík: Semaglutide as a Strategy for Primary Prevention of Cerebrovascular Disease in RA
-
Jun 24, 2026, 19:43New ASH/ISTH 2026 Guidelines for Pediatric Anticoagulant Prophylaxis of VTE Are Now Live – Blood Journals Portfolio
-
Jun 24, 2026, 18:36Maryam Sardar: Timely Anticoagulation in SMV Thrombosis Complicating Acute Pancreatitis
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored